Patients with prostate cancer and BRCA2 mutations need urgent treatment

被引：0
|
作者：
Torjesen, Ingrid
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 346卷
关键词：
D O I：
10.1136/bmj.f2223
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prostate cancer patients with BRCA2 mutations require urgent treatment
    Eles, Ros
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (05) : 250 - 250
  • [2] Mutations in BRCA2 and taxane resistance in prostate cancer
    Cathleen Nientiedt
    Martina Heller
    Volker Endris
    Anna-Lena Volckmar
    Stefanie Zschäbitz
    María A. Tapia-Laliena
    Anette Duensing
    Dirk Jäger
    Peter Schirmacher
    Holger Sültmann
    Albrecht Stenzinger
    Markus Hohenfellner
    Carsten Grüllich
    Stefan Duensing
    [J]. Scientific Reports, 7
  • [3] Mutations in BRCA2 and taxane resistance in prostate cancer
    Nientiedt, Cathleen
    Heller, Martina
    Endris, Volker
    Volckmar, Anna-Lena
    Zschaebitz, Stefanie
    Tapia-Laliena, Maria A.
    Duensing, Anette
    Jaeger, Dirk
    Schirmacher, Peter
    Sueltmann, Holger
    Stenzinger, Albrecht
    Hohenfellner, Markus
    Gruellich, Carsten
    Duensing, Stefan
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [4] Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer
    Tischkowitz, M
    Eeles, R
    [J]. LANCET, 2003, 362 (9377): : 80 - 80
  • [5] Are prostate cancer patients with BRCA1 and BRCA2 mutations safe for active surveillance?
    Dall'era, Marc
    Evans, Christopher P.
    Pan, Chong-Xian
    Parikh, Mamta
    Lara, Primo
    McPherson, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [6] BRCA2 Mutations in Prostate Cancer Assort Into Cluster Regions
    Patel, V. L.
    Busch, E.
    D'Amico, A. V.
    Rebbeck, T. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E569 - E570
  • [7] The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
    Vezina, A.
    Baniel, J.
    Yaacobi, Y.
    Shtriker, A.
    Engelstein, D.
    Leibovitz, I.
    Zehavi, M.
    Sidi, A. A.
    Ramon, Y.
    Tischler, T.
    Livne, P. M.
    Friedman, E.
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 463 - 466
  • [8] The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
    A Vazina
    J Baniel
    Y Yaacobi
    A Shtriker
    D Engelstein
    I Leibovitz
    M Zehavi
    A A Sidi
    Y Ramon
    T Tischler
    P M Livne
    E Friedman
    [J]. British Journal of Cancer, 2000, 83 : 463 - 466
  • [9] Cancer treatment according to BRCA1 and BRCA2 mutations
    Kara N. Maxwell
    Susan M. Domchek
    [J]. Nature Reviews Clinical Oncology, 2012, 9 : 520 - 528
  • [10] Cancer treatment according to BRCA1 and BRCA2 mutations
    Maxwell, Kara N.
    Domchek, Susan M.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (09) : 520 - 528
12345